Cargando…
Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis
BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251690/ https://www.ncbi.nlm.nih.gov/pubmed/37291493 http://dx.doi.org/10.1186/s12885-023-10805-6 |
_version_ | 1785055996881666048 |
---|---|
author | Li, Yiding Wu, Guiling Liu, Jinqiang Zhang, Yujie Yang, Wanli Wang, Xiaoqian Duan, Lili Niu, Liaoran Chen, Junfeng Zhou, Wei Han, Weili Wang, Jing Zhong, Helun Ji, Gang Fan, Daiming Hong, Liu |
author_facet | Li, Yiding Wu, Guiling Liu, Jinqiang Zhang, Yujie Yang, Wanli Wang, Xiaoqian Duan, Lili Niu, Liaoran Chen, Junfeng Zhou, Wei Han, Weili Wang, Jing Zhong, Helun Ji, Gang Fan, Daiming Hong, Liu |
author_sort | Li, Yiding |
collection | PubMed |
description | BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival (OS) of gastric cancer (GC). METHODS: Through a systematic review till March 7, 2022, we identified population-based studies that reported the prognostic effects of LODDS in patients with GC. We compare the predictive effectiveness of the LODDS staging system with that of the rN and pN classification systems for the OS of GC. RESULTS: Twelve studies comprising 20,312 patients were included in this systematic review and meta-analysis. The results showed that LODDS1, LODDS2, LODDS3, and LODDS4 in GC patients were correlated with poor OS compared with LODDS0 (LODDS1 vs. LODDS0: HR = 1.62, 95% CI (1.42, 1.85); LODDS2 vs. LODDS0: HR = 2.47, 95% CI (2.02, 3.03); LODDS3 vs. LODDS0: HR = 3.15, 95% CI (2.50, 3.97); LODDS4 vs. LODDS0: HR = 4.55, 95% CI (3.29, 6.29)). Additionally, significant differences in survival were observed among patients with different LODDS classifications (all P-values were < 0.001) with the same rN and pN classifications. Meanwhile, for patients with different pN or rN classifications with the same LODDS classification, prognosis was highly similar. CONCLUSION: The findings show that LODDS is correlated with the prognosis of GC patients and is superior to the pN and rN classifications for prognostic assessment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10805-6. |
format | Online Article Text |
id | pubmed-10251690 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102516902023-06-10 Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis Li, Yiding Wu, Guiling Liu, Jinqiang Zhang, Yujie Yang, Wanli Wang, Xiaoqian Duan, Lili Niu, Liaoran Chen, Junfeng Zhou, Wei Han, Weili Wang, Jing Zhong, Helun Ji, Gang Fan, Daiming Hong, Liu BMC Cancer Research BACKGROUND: We conducted a systematic review and meta-analysis to summarize the predictive and prognostic ability of the log odds of positive lymph nodes (LODDS) staging system and compare it with pathological N (pN) classification and the ratio-based lymph node system (rN) for the overall survival (OS) of gastric cancer (GC). METHODS: Through a systematic review till March 7, 2022, we identified population-based studies that reported the prognostic effects of LODDS in patients with GC. We compare the predictive effectiveness of the LODDS staging system with that of the rN and pN classification systems for the OS of GC. RESULTS: Twelve studies comprising 20,312 patients were included in this systematic review and meta-analysis. The results showed that LODDS1, LODDS2, LODDS3, and LODDS4 in GC patients were correlated with poor OS compared with LODDS0 (LODDS1 vs. LODDS0: HR = 1.62, 95% CI (1.42, 1.85); LODDS2 vs. LODDS0: HR = 2.47, 95% CI (2.02, 3.03); LODDS3 vs. LODDS0: HR = 3.15, 95% CI (2.50, 3.97); LODDS4 vs. LODDS0: HR = 4.55, 95% CI (3.29, 6.29)). Additionally, significant differences in survival were observed among patients with different LODDS classifications (all P-values were < 0.001) with the same rN and pN classifications. Meanwhile, for patients with different pN or rN classifications with the same LODDS classification, prognosis was highly similar. CONCLUSION: The findings show that LODDS is correlated with the prognosis of GC patients and is superior to the pN and rN classifications for prognostic assessment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-023-10805-6. BioMed Central 2023-06-08 /pmc/articles/PMC10251690/ /pubmed/37291493 http://dx.doi.org/10.1186/s12885-023-10805-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Yiding Wu, Guiling Liu, Jinqiang Zhang, Yujie Yang, Wanli Wang, Xiaoqian Duan, Lili Niu, Liaoran Chen, Junfeng Zhou, Wei Han, Weili Wang, Jing Zhong, Helun Ji, Gang Fan, Daiming Hong, Liu Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title | Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title_full | Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title_fullStr | Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title_full_unstemmed | Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title_short | Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
title_sort | log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251690/ https://www.ncbi.nlm.nih.gov/pubmed/37291493 http://dx.doi.org/10.1186/s12885-023-10805-6 |
work_keys_str_mv | AT liyiding logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT wuguiling logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT liujinqiang logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT zhangyujie logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT yangwanli logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT wangxiaoqian logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT duanlili logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT niuliaoran logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT chenjunfeng logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT zhouwei logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT hanweili logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT wangjing logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT zhonghelun logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT jigang logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT fandaiming logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis AT hongliu logoddsofpositivelymphnodesasanovelprognosticpredictorforgastriccancerasystematicreviewandmetaanalysis |